HUP0402225A3 - Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them - Google Patents

Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HUP0402225A3
HUP0402225A3 HU0402225A HUP0402225A HUP0402225A3 HU P0402225 A3 HUP0402225 A3 HU P0402225A3 HU 0402225 A HU0402225 A HU 0402225A HU P0402225 A HUP0402225 A HU P0402225A HU P0402225 A3 HUP0402225 A3 HU P0402225A3
Authority
HU
Hungary
Prior art keywords
macrolide
compounds
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU0402225A
Other languages
English (en)
Original Assignee
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Istrazivacki Inst D O O filed Critical Pliva Istrazivacki Inst D O O
Publication of HUP0402225A2 publication Critical patent/HUP0402225A2/hu
Publication of HUP0402225A3 publication Critical patent/HUP0402225A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
HU0402225A 2001-11-14 2002-11-13 Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them HUP0402225A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0127349.9A GB0127349D0 (en) 2001-11-14 2001-11-14 Macrolides
PCT/GB2002/005101 WO2003042228A1 (en) 2001-11-14 2002-11-13 Macrolides

Publications (2)

Publication Number Publication Date
HUP0402225A2 HUP0402225A2 (hu) 2005-02-28
HUP0402225A3 true HUP0402225A3 (en) 2006-01-30

Family

ID=9925777

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402225A HUP0402225A3 (en) 2001-11-14 2002-11-13 Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US7202221B2 (hu)
EP (1) EP1453846B1 (hu)
JP (1) JP2005515978A (hu)
CN (1) CN1307194C (hu)
AR (1) AR037371A1 (hu)
AT (1) ATE362479T1 (hu)
BR (1) BR0214132A (hu)
CA (1) CA2466975A1 (hu)
DE (1) DE60220180T2 (hu)
EA (1) EA007433B1 (hu)
ES (1) ES2287332T3 (hu)
GB (1) GB0127349D0 (hu)
HR (1) HRP20040433A2 (hu)
HU (1) HUP0402225A3 (hu)
IL (1) IL161710A0 (hu)
PL (1) PL371472A1 (hu)
RS (1) RS41904A (hu)
UA (1) UA77210C2 (hu)
WO (1) WO2003042228A1 (hu)
ZA (1) ZA200403684B (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7022679B2 (en) 2002-05-13 2006-04-04 Enanta Pharmaceuticals, Inc. Processes for the preparation of 6-11 bicyclic erythromycin derivatives
KR20040107525A (ko) * 2002-05-14 2004-12-20 더 리전트 오브 더 유니버시티 오브 캘리포니아 치환된 퀴놀론 카르복실산, 이들의 유도체, 그의 작용부위 및 용도
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310986D0 (en) 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
PT1628989E (pt) * 2003-05-13 2007-03-30 Glaxo Group Ltd Novos compostos anelares com 14 e 15 membros
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
WO2005030227A1 (en) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
US7265094B2 (en) 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
WO2005108413A1 (en) * 2004-05-06 2005-11-17 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O Carbamate linked macrolides useful for the treatment of microbial infections
AU2005240849B2 (en) * 2004-05-06 2008-10-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ester linked macrolides useful for the treatment of microbial infections
WO2006047167A2 (en) * 2004-10-21 2006-05-04 Janssen Pharmaceutica, N.V. 9 alkyl and 9 alkylidenyl 6-0 alkyl-11, 12 carbamate ketolide antimicrobials
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424959D0 (en) 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424951D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
KR101239490B1 (ko) 2006-08-09 2013-03-05 바실리어 파마슈티카 아게 염증성 및 알러지성 질환에 유용한 새로운 마크로라이드
JP2010501541A (ja) 2006-08-24 2010-01-21 ウォックハート リサーチ センター 抗菌活性を有する新規マクロライド及びケトライド
JP5651019B2 (ja) 2008-02-08 2015-01-07 バジリア ファルマスーチカ アーゲーＢａｓｉｌｅａ Ｐｈａｒｍａｃｅｕｔｉｃａ ＡＧ 新規マクロライドおよびそれらの使用
US8541420B2 (en) 2009-05-27 2013-09-24 Wockhardt Ltd. Ketolide compounds having antimicrobial activity
CA2820451C (en) 2010-12-09 2017-12-12 Wockhardt Limited Ketolide compounds
US20140011757A1 (en) * 2011-01-31 2014-01-09 Meiji Seika Pharma Co., Ltd. Novel macrolide derivative
EP2681222B1 (en) 2011-03-01 2018-02-28 Wockhardt Limited Process for preparation of ketolide intermediates

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126344A2 (en) 1983-05-20 1984-11-28 Abbott Laboratories Tripeptide esters of therapeutic agents
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
JPH04504259A (ja) * 1989-03-28 1992-07-30 アボツト・ラボラトリーズ エリスロマイシン誘導体
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
ES2252784T3 (es) 1996-05-07 2006-05-16 Abbott Laboratories Compuestos a base de eritromicina 6-0 sustituida y tecnica de produccion.
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
US6262030B1 (en) * 1998-11-03 2001-07-17 Pfizer Inc. Erythromycin derivatives
OA11945A (en) 1999-05-24 2006-04-13 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
BR0009101A (pt) 1999-08-24 2002-02-05 Abbott Lab 9a-azalidas com atividade antibacteriana
US6946446B2 (en) * 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
EP1259923B1 (en) 2000-02-24 2005-12-14 Abbott Laboratories Anti-infective agents useful against mulitidrug-resistant strains of bacteria
JP2002173498A (ja) 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
GB0025688D0 (en) 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
ES2287332T3 (es) 2007-12-16
CA2466975A1 (en) 2003-05-22
US7202221B2 (en) 2007-04-10
ZA200403684B (en) 2005-09-13
UA77210C2 (en) 2006-11-15
HRP20040433A2 (en) 2005-04-30
JP2005515978A (ja) 2005-06-02
US20050080025A1 (en) 2005-04-14
BR0214132A (pt) 2004-09-14
EP1453846B1 (en) 2007-05-16
PL371472A1 (en) 2005-06-13
DE60220180D1 (de) 2007-06-28
WO2003042228A1 (en) 2003-05-22
CN1612888A (zh) 2005-05-04
EA007433B1 (ru) 2006-10-27
RS41904A (en) 2006-10-27
AR037371A1 (es) 2004-11-03
EP1453846A1 (en) 2004-09-08
DE60220180T2 (de) 2008-01-17
EA200400536A1 (ru) 2004-12-30
GB0127349D0 (en) 2002-01-02
HUP0402225A2 (hu) 2005-02-28
ATE362479T1 (de) 2007-06-15
IL161710A0 (en) 2004-09-27
CN1307194C (zh) 2007-03-28

Similar Documents

Publication Publication Date Title
HUP0402225A3 (en) Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them
HUP0301187A3 (en) Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
HUP0303458A3 (en) 6-substituted pyrido-pyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0301069A3 (en) Novel biarylcarboxamides, process for their preparation, pharmaceutical compositions containing them and their use
HUP0402063A3 (en) Indole-2-carboxamides process for producing them, pharmaceutical compositions containing them and use thereof
HUP0401619A3 (en) Phenethanolamine derivatives, process for their preparation and pharmaceutical composition containing them
HU0103063D0 (en) New 2h-pyridazin-3-one derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
HUP0400040A2 (hu) Szulfonamidok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0100489A3 (en) New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0401082A3 (en) Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them
AU2003231920A8 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
HUP0301254A3 (en) Novel compounds, process fo their preparation and pharmaceutical compositions containing them
HUP0204001A3 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0303361A3 (en) Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0302429A3 (en) 4-amino-quinazolines, process for producing them, pharmaceutical compositions containing them and their use
HUP0204394A3 (en) Tetrahydropyridines, process for their preparation, pharmaceutical compositions containing them and use thereof
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
HUP0201024A3 (en) Izoindeindolone compounds, process for their preparation and pharmaceutical compositions containing them
HUP0302905A3 (en) Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them
SI1241169T1 (en) Isoindoloindolone derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0300066A3 (en) Polypeptide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0401038A3 (en) Piperazinylcarbonylquinolines and -isoquinolines, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees